Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Short-Term Debt

$400.70M

Quarterly · Period ending: · USD

BIO logo

BIO Short-Term Debt

Latest reported$400.70M
BIO Quarterly Short-Term Debt ($8.60M → $400.70M)
High-resolution chart · PNG

BIO short-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Short-Term Debt — Quarterly (USD)
Period endingShort-Term Debt (USD)
400,700,000
436,700,000
37,900,000
38,100,000
40,600,000
42,500,000
42,900,000
44,096,000
41,996,000
40,525,000
40,865,000
39,592,000
37,019,000
36,668,000
36,801,000
34,443,000
36,235,000
37,743,000
36,924,000
37,762,000
37,308,000
40,935,000
38,307,000
460,987,000
460,441,000
460,740,000
461,565,000
35,494,000
35,733,000
36,213,000
493,000
1,772,000
1,721,000
369,000
420,000
452,000
505,000
466,000
334,000
297,000
294,000
296,000
298,000
379,000
268,000
264,000
265,000
1,471,000
1,725,000
1,732,000
1,786,000
1,705,000
1,693,000
1,698,000
1,750,000
306,000
783,000
809,000
814,000
806,000
1,363,000
10,269,000
233,181,000
9,161,000
9,750,000
5,104,000
5,132,000
5,346,000
5,874,000
6,253,000
9,578,000
11,886,000
14,680,000
15,677,000
15,627,000
4,907,000
4,604,000
4,609,000
3,042,000
3,768,000
4,478,000
3,785,000
3,341,000
8,985,000
11,479,000
9,658,000
9,457,000
8,457,000
9,987,000
8,530,000
10,423,000
9,612,000
13,405,000
11,146,000
7,486,000
10,385,000
11,156,000
10,095,000
9,931,000
19,993,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.